Valens Semiconductor Rule 144 notice for 338,090 share sale

Valens Semiconductor filed a notice covering a planned sale of ordinary shares under Rule 144.

Accepted by SEC EDGAR 01/09/2026 - 04:32 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Valens Semiconductor filed a notice covering a planned sale of ordinary shares under Rule 144. The filing indicates an intention to sell 338,090 ordinary shares through broker Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $527,420.40. These shares are part of a larger base of 106,342,415 shares outstanding. The securities to be sold were acquired on 11/30/2023 via distributions in kind from Genesis Partners III and VALENS S.P.V., meaning they were received as part of a non-cash distribution rather than a direct cash purchase. The approximate sale date listed is 01/09/2026, and the person on whose behalf the sale is planned represents that they are not aware of any undisclosed material adverse information about the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Valens Semiconductor (VLN) disclose in this Rule 144 filing?

The filing discloses a planned sale of 338,090 ordinary shares of Valens Semiconductor under Rule 144, to be executed through Oppenheimer & Co. Inc. on the NYSE.

How many Valens Semiconductor (VLN) shares are planned to be sold and what is their value?

The notice covers 338,090 ordinary shares with an aggregate market value of $527,420.40, based on the information in the filing.

When were the Valens Semiconductor (VLN) shares to be sold under Rule 144 acquired?

The ordinary shares to be sold were acquired on 11/30/2023 through distributions in kind from Genesis Partners III and VALENS S.P.V.

When is the approximate sale date for the Valens Semiconductor (VLN) shares in this notice?

The filing lists an approximate sale date of 01/09/2026 for the planned Rule 144 transaction.

On which exchange will the Valens Semiconductor (VLN) shares be sold?

The notice states that the ordinary shares are expected to be sold on the NYSE, with Oppenheimer & Co. Inc. acting as broker.

What representation does the selling person make in this Valens Semiconductor (VLN) Rule 144 notice?

The person for whose account the securities are to be sold represents that they do not know of any material adverse information about Valens Semiconductor's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001899771
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Valens Semiconductor Ltd.
SEC File Number	001-40842
Address of Issuer	8 HANAGAR ST. POB 7152 HOD HASHARON, 4501309 ISRAEL 00000
Phone	972-9-762-6900
Name of Person for Whose Account the Securities are To Be Sold	Kishon Eyal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 broad st. New York NY 10004	338090	527420.40	106342415	01/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	11/30/2023	Distribution in Kind	Genesis Partners III			333096	11/30/2023	N/A
Ordinary	11/30/2023	Distribution in Kind	VALENS S.P.V.			4994	11/30/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Eyal Kishon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)